91 related articles for article (PubMed ID: 18024949)
1. Blood glucose and cerebrovascular disease in nondiabetic patients.
Nielson C; Fleming RM
Angiology; 2007; 58(5):625-9. PubMed ID: 18024949
[TBL] [Abstract][Full Text] [Related]
2. Blood glucose and coronary artery disease in nondiabetic patients.
Nielson C; Lange T; Hadjokas N
Diabetes Care; 2006 May; 29(5):998-1001. PubMed ID: 16644627
[TBL] [Abstract][Full Text] [Related]
3. Increased risk of stroke and transient ischemic attack in 5-year survivors of Hodgkin lymphoma.
De Bruin ML; Dorresteijn LD; van't Veer MB; Krol AD; van der Pal HJ; Kappelle AC; Boogerd W; Aleman BM; van Leeuwen FE
J Natl Cancer Inst; 2009 Jul; 101(13):928-37. PubMed ID: 19535773
[TBL] [Abstract][Full Text] [Related]
4. Major vascular events after transient ischaemic attack and minor ischaemic stroke: post hoc modelling of incidence dynamics.
Atanassova PA; Chalakova NT; Dimitrov BD
Cerebrovasc Dis; 2008; 25(3):225-33. PubMed ID: 18216464
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of abnormal glucose tolerance following a transient ischemic attack or ischemic stroke.
Kernan WN; Viscoli CM; Inzucchi SE; Brass LM; Bravata DM; Shulman GI; McVeety JC
Arch Intern Med; 2005 Jan; 165(2):227-33. PubMed ID: 15668371
[TBL] [Abstract][Full Text] [Related]
6. Causes of recurrent focal neurologic events after transcatheter closure of patent foramen ovale with the CardioSEAL septal occluder.
Kutty S; Brown K; Asnes JD; Rhodes JF; Latson LA
Am J Cardiol; 2008 May; 101(10):1487-92. PubMed ID: 18471463
[TBL] [Abstract][Full Text] [Related]
7. Peroxisome proliferator-activated receptor ligand bezafibrate for prevention of type 2 diabetes mellitus in patients with coronary artery disease.
Tenenbaum A; Motro M; Fisman EZ; Schwammenthal E; Adler Y; Goldenberg I; Leor J; Boyko V; Mandelzweig L; Behar S
Circulation; 2004 May; 109(18):2197-202. PubMed ID: 15123532
[TBL] [Abstract][Full Text] [Related]
8. Impaired fasting glucose concentrations in nondiabetic patients with ischemic heart disease: a marker for a worse prognosis.
Fisman EZ; Motro M; Tenenbaum A; Boyko V; Mandelzweig L; Behar S
Am Heart J; 2001 Mar; 141(3):485-90. PubMed ID: 11231448
[TBL] [Abstract][Full Text] [Related]
9. Association of elevated fasting glucose with increased short-term and 6-month mortality in ST-segment elevation and non-ST-segment elevation acute coronary syndromes: the Global Registry of Acute Coronary Events.
Sinnaeve PR; Steg PG; Fox KA; Van de Werf F; Montalescot G; Granger CB; Knobel E; Anderson FA; Dabbous OH; Avezum A;
Arch Intern Med; 2009 Feb; 169(4):402-9. PubMed ID: 19237725
[TBL] [Abstract][Full Text] [Related]
10. Normal fasting plasma glucose and risk of type 2 diabetes diagnosis.
Nichols GA; Hillier TA; Brown JB
Am J Med; 2008 Jun; 121(6):519-24. PubMed ID: 18501234
[TBL] [Abstract][Full Text] [Related]
11. Impaired glucose tolerance is a risk factor for stroke in a Japanese sample--the Funagata study.
Oizumi T; Daimon M; Jimbu Y; Wada K; Kameda W; Susa S; Yamaguchi H; Ohnuma H; Tominaga M; Kato T
Metabolism; 2008 Mar; 57(3):333-8. PubMed ID: 18249204
[TBL] [Abstract][Full Text] [Related]
12. Effect of age and glycaemic control on the association between fibrinogen and risk of acute coronary events after transient ischaemic attack or stroke.
Howard SC; Algra A; Rothwell PM;
Cerebrovasc Dis; 2008; 25(1-2):136-43. PubMed ID: 18073467
[TBL] [Abstract][Full Text] [Related]
13. A 52-week, randomized, open-label, parallel-group comparison of the tolerability and effects of pitavastatin and atorvastatin on high-density lipoprotein cholesterol levels and glucose metabolism in Japanese patients with elevated levels of low-density lipoprotein cholesterol and glucose intolerance.
Sasaki J; Ikeda Y; Kuribayashi T; Kajiwara K; Biro S; Yamamoto K; Ageta M; Kobori S; Saikawa T; Otonari T; Kono S
Clin Ther; 2008 Jun; 30(6):1089-101. PubMed ID: 18640465
[TBL] [Abstract][Full Text] [Related]
14. C-reactive protein gene C1444T polymorphism and risk of recurrent ischemic events in patients with symptomatic intracranial atherostenoses.
Arenillas JF; Massot A; Alvarez-Sabín J; Fernandez-Cadenas I; del Rio-Espinola A; Chacon P; Quintana M; Molina CA; Rovira A; Montaner J
Cerebrovasc Dis; 2009; 28(1):95-102. PubMed ID: 19494488
[TBL] [Abstract][Full Text] [Related]
15. Hyperresponsiveness of platelets in ischemic stroke.
Fateh-Moghadam S; Htun P; Tomandl B; Sander D; Stellos K; Geisler T; Langer H; Walton K; Handschu R; Garlichs C; Daniel WG; Gawaz M
Thromb Haemost; 2007 Jun; 97(6):974-8. PubMed ID: 17549300
[TBL] [Abstract][Full Text] [Related]
16. Current management and risk of recurrent stroke in cerebrovascular patients with right-to-left cardiac shunt.
Weimar C; Holle DN; Benemann J; Schmid E; Schminke U; Haberl RL; Diener HC; Goertler M;
Cerebrovasc Dis; 2009; 28(4):349-56. PubMed ID: 19628936
[TBL] [Abstract][Full Text] [Related]
17. The incidence of heart failure among nondiabetic patients with and without impaired fasting glucose.
Nichols GA; Koro CE; Kolatkar NS
J Diabetes Complications; 2009; 23(3):224-8. PubMed ID: 18413158
[TBL] [Abstract][Full Text] [Related]
18. Detection of undiagnosed diabetes and prediabetic states in high-risk emergency department patients.
Charfen MA; Ipp E; Kaji AH; Saleh T; Qazi MF; Lewis RJ
Acad Emerg Med; 2009 May; 16(5):394-402. PubMed ID: 19302369
[TBL] [Abstract][Full Text] [Related]
19. Leukocyte count and vascular risk in symptomatic intracranial atherosclerosis.
Ovbiagele B; Lynn MJ; Saver JL; Chimowitz MI;
Cerebrovasc Dis; 2007; 24(2-3):283-8. PubMed ID: 17646693
[TBL] [Abstract][Full Text] [Related]
20. Decreased risk of stroke among 10-year survivors of breast cancer.
Hooning MJ; Dorresteijn LD; Aleman BM; Kappelle AC; Klijn JG; Boogerd W; van Leeuwen FE
J Clin Oncol; 2006 Dec; 24(34):5388-94. PubMed ID: 17088569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
